Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Qianying Zuo"'
Autor:
Ayca Nazli Mogol, Qianying Zuo, Jin Young Yoo, Alanna Zoe Kaminsky, Ozan Berk Imir, Yosef Landesman, Christopher J Walker, Zeynep Madak Erdogan
Publikováno v:
Endocrinology.
Approximately 70% of human breast cancers express estrogen receptor-α (ERα), providing a potential target for endocrine therapy. However, 30%–40% of patients with ER+ breast cancer still experiences recurrence and metastasis, with a 5-year relati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d99389303a9abf4998eb023919b966f9
https://doi.org/10.1210/endocr/bqad073
https://doi.org/10.1210/endocr/bqad073
Autor:
Zeynep Madak Erdogan, Debu Tripathy, Akshara Singareeka Raghavendra, John D. O'Neill, Evelyn Aranda, Benita S. Katzenellenbogen, Yvonne Ziegler, Ben Ho Park, David J. Shapiro, Nicole Hwajin Park, Eylem Kulkoyluoglu-Cotul, Ozan Berk Imir, Jenny Drnevich, Christine Chien, Ashlie Santaliz Casiano, Yu-Jeh Liu, Ayca Nazli Mogol, Qianying Zuo
Supplementary Table from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08fcbd670914710b64958120b07b5ee2
https://doi.org/10.1158/1541-7786.22528229.v1
https://doi.org/10.1158/1541-7786.22528229.v1
Autor:
Zeynep Madak Erdogan, Debu Tripathy, Akshara Singareeka Raghavendra, John D. O'Neill, Evelyn Aranda, Benita S. Katzenellenbogen, Yvonne Ziegler, Ben Ho Park, David J. Shapiro, Nicole Hwajin Park, Eylem Kulkoyluoglu-Cotul, Ozan Berk Imir, Jenny Drnevich, Christine Chien, Ashlie Santaliz Casiano, Yu-Jeh Liu, Ayca Nazli Mogol, Qianying Zuo
Estrogen receptor–positive (ER+) metastatic tumors contribute to nearly 70% of breast cancer–related deaths. Most patients with ER+ metastatic breast cancer (MBC) undergo treatment with the estrogen receptor antagonist fulvestrant as standard of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10b4132d6b56eba42f1eb12d4ae2f62b
https://doi.org/10.1158/1541-7786.c.6545651.v1
https://doi.org/10.1158/1541-7786.c.6545651.v1
Publikováno v:
Nutrients. 14(12)
The median overall survival of patients with metastatic breast cancer is only 2–3 years, and for patients with untreated liver metastasis, it is as short as 4–8 months. Improving the survival of women with breast cancer requires more effective an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc0d4745e9fd4ad51a36d4994d8c8a69
https://pubmed.ncbi.nlm.nih.gov/35745105
https://pubmed.ncbi.nlm.nih.gov/35745105
Autor:
Wen-Yang Hu, Ranli Lu, Dan Ping Hu, Ozan Berk Imir, Qianying Zuo, Dan Moline, Parivash Afradiasbagharani, Lifeng Liu, Scott Lowe, Lynn Birch, Donald J. Vander Griend, Zeynep Madak-Erdogan, Gail S. Prins
Publikováno v:
Biochem Pharmacol
Per- and polyfluorinated alkyl substances (PFAS) are a large family of widely used synthetic chemicals that are environmentally and biologically persistent and present in most individuals. Chronic PFAS exposure have been linked to increased prostate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd5bb801e707b5b13b112314fb8b88e
https://europepmc.org/articles/PMC8890783/
https://europepmc.org/articles/PMC8890783/
Autor:
Sung Hoon Kim, John A. Katzenellenbogen, Benita S. Katzenellenbogen, Karen L. Chen, Alicia Arredondo Eve, Qianying Zuo, Yu Jeh Liu, Zeynep Madak-Erdogan
Publikováno v:
Nutrients
Volume 13
Issue 10
Nutrients, Vol 13, Iss 3334, p 3334 (2021)
Volume 13
Issue 10
Nutrients, Vol 13, Iss 3334, p 3334 (2021)
About 20–30% of premenopausal women have metabolic syndrome, and the number is almost double in postmenopausal women, and these women have an increased risk of hepatosteatosis. Postmenopausal women with metabolic syndrome are often treated with hor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::894715e8eaf99c3434ce6880053e28f2
Autor:
Yu-Jeh Liu, Ozan Berk Imir, David J. Shapiro, Yvonne S. Ziegler, Qianying Zuo, Jenny Drnevich, Evelyn Aranda, Zeynep Madak-Erdogan, Ashlie Santaliz Casiano, C. Chien, Debu Tripathy, N. H. Park, A. N. Mogol, Eylem Kulkoyluoglu-Cotul, Benita S. Katzenellenbogen, Ben Ho Park, A. S. Raghavendra, John D. O’Neill
Publikováno v:
Mol Cancer Res
Estrogen receptor-positive (ER+) metastatic tumors contribute to nearly 70% of breast cancer-related deaths. Most patients with ER+ metastatic breast cancer (MBC) undergo treatment with the estrogen receptor antagonist fulvestrant (Fulv) as standard-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194582c788d79991066b0614024b916a
https://doi.org/10.1101/2021.09.07.458711
https://doi.org/10.1101/2021.09.07.458711
Autor:
Ayca Mogol, Christine Chien, Qianying Zuo, Akshara Singareeka Raghavendra, Debu Tripathy, Yosef Landesman, Zeynep Madak-Erdogan
Publikováno v:
Journal of the Endocrine Society. 6:A879-A879
Approximately 70% of human breast cancers express estrogen receptor alpha (ERα), providing a potential for targeted endocrine therapy for patients. Unfortunately, 30-40% of ER+ patients still experience recurrence and metastasis, with a 5-year relat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d543277b81f072682fedf22e357dff3
https://doi.org/10.1210/jendso/bvac150.1819
https://doi.org/10.1210/jendso/bvac150.1819
Publikováno v:
Endocrinology. 162(12)
Obesity is a potential risk for several cancers, including postmenopausal, hormone dependent breast cancers. In this review, we summarize recent studies on the impact of obesity on postmenopausal women’s health and discuss several mechanisms that w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2cb42809a0176115854e717bf8755a7
https://pubmed.ncbi.nlm.nih.gov/34519778
https://pubmed.ncbi.nlm.nih.gov/34519778
Autor:
Meera Patel, Brandi Patrice Smith, Eylem Kulkoyluoglu-Cotul, Qianying Zuo, Gianluigi Rossi, Anna Maria Storniolo, Shoham Band, Jodi A. Flaws, Zeynep Madak-Erdogan, Ashlie Santaliz Casiano, Yiru C. Zhao, Rebecca L. Smith, John A. Katzenellenbogen, Natascia Marino, Kinga Wrobel, Sung Hoon Kim, Mariah L. Johnson
Publikováno v:
Cancer Research. 79:2494-2510
Obesity is a risk factor for postmenopausal estrogen receptor alpha (ERα)-positive (ER+) breast cancer. Molecular mechanisms underlying factors from plasma that contribute to this risk and how these mechanisms affect ERα signaling have yet to be el
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5edb83b04489546778099cca1cdb8743
https://doi.org/10.1158/0008-5472.can-18-2849
https://doi.org/10.1158/0008-5472.can-18-2849